Twist in the TRIPS tale

UK panel endorses South's stand on intellectual property rights

Karnataka villagers suspect biodiversity register

Coronavirus vaccines: TRIPS waiver caught in WTO labyrinth

Little change in the position of countries opposing waiver of intellectual property rights; India-South Africa proposal being through hoops …

Ignore US bullying on IPRs

Countries should not be stampeded into changing laws by the USTR's arbitrary Special 301 report

Government's agri-research set-up is undemocratic

India, US tie their first IPR knot

Water in a sieve

Don’t confine global resources to national boundaries

The innovation WHO needs

The strategy to push public health, innovation and intellectual property is a tough challenge because of funding constraints

FARM IP, ENTER WIPO

Developing countries will now have to battle IP issues related to new agricultural technologies at WIPO instead of WTO

Brickbats for compulsory licences

US criticises India and BRIC group for strengthening provisions on life-saving medicines

A patent triumph of public interest

New flexibilities make public interest safeguards integral to drug patent rights

Strong medicine for weak drug patents

Revocation of Pfizer, Roche patents for lacking inventive step signals healthy trend

Biodiversity—India’s other scandal

CAG slams the national biodiversity authority for allowing questionable patents

Public Funded R&D Bill may benefit the private sector

Free trade will bind India

CAG report highlights glaring issues with functioning of key scientific institutions

Institute for Plasma Research and Indian Institute of Chemical Technology pulled up

ICAR gives top award to scientist without checking patent claims

ICAR has asked for Rs 245 crore to promote intellectual property rights but is not doing due diligence on patent claims

Crazy for GI? Think again

The protection of Geographical Indication is not a guarantee that the artisan or producer will benefit; traders can corner the premium

A rather ridiculous gap

Clothing giant Gap’s trademark infringement notice to an NGO selling products made from recycled waste is a curious case

The fine line for judges

Judges have recused themselves in a number of cases but there are no clear guidelines on what constitutes conflict of interest  

Legislation for a few

Benefits of the Act that encourages conservation of plants reach few farmers

NCD battle starts now

The UN agreement on non-communicable diseases will get snagged on the issue of intellectual property rights for drugs

Obama takes first dip

The US becomes the first to join a global patents pool to make AIDS drugs cheaper but health workers are sceptical of the initiative

Access, yes. Sharing, no

The access and benefit-sharing protocol on biodiversity may do little to deter multinationals from grabbing the planet’s resources

Yale guide to fighting drug patent barriers

How human rights can be used to challenge oppressive intellectual property laws